EXOSENS SAS (EXENS.PA) Stock Fundamental Analysis
EPA:EXENS - Euronext Paris - Matif - FR001400Q9V2 - Common Stock - Currency: EUR
Overall EXENS gets a fundamental rating of 6 out of 10. We evaluated EXENS against 47 industry peers in the Aerospace & Defense industry. EXENS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. EXENS is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make EXENS suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year EXENS was profitable.
EXENS had a positive operating cash flow in the past year.
1.2 Ratios
EXENS has a Return On Assets of 3.76%. This is comparable to the rest of the industry: EXENS outperforms 57.45% of its industry peers.
With a Return On Equity value of 7.44%, EXENS perfoms like the industry average, outperforming 44.68% of the companies in the same industry.
EXENS has a Return On Invested Capital of 8.34%. This is in the better half of the industry: EXENS outperforms 61.70% of its industry peers.
EXENS had an Average Return On Invested Capital over the past 3 years of 7.01%. This is in line with the industry average of 8.60%.
The last Return On Invested Capital (8.34%) for EXENS is above the 3 year average (7.01%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.76% | ||
| ROE | 7.44% | ||
| ROIC | 8.34% |
ROA(3y)2.89%
ROA(5y)N/A
ROE(3y)7.53%
ROE(5y)N/A
ROIC(3y)7.01%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of EXENS (7.79%) is better than 78.72% of its industry peers.
Looking at the Operating Margin, with a value of 18.28%, EXENS belongs to the top of the industry, outperforming 97.87% of the companies in the same industry.
EXENS has a better Gross Margin (73.86%) than 97.87% of its industry peers.
In the last couple of years the Gross Margin of EXENS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.28% | ||
| PM (TTM) | 7.79% | ||
| GM | 73.86% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EXENS is still creating some value.
The number of shares outstanding for EXENS has been reduced compared to 1 year ago.
The debt/assets ratio for EXENS has been reduced compared to a year ago.
2.2 Solvency
EXENS has an Altman-Z score of 4.21. This indicates that EXENS is financially healthy and has little risk of bankruptcy at the moment.
EXENS has a better Altman-Z score (4.21) than 78.72% of its industry peers.
EXENS has a debt to FCF ratio of 4.75. This is a neutral value as EXENS would need 4.75 years to pay back of all of its debts.
EXENS has a Debt to FCF ratio of 4.75. This is comparable to the rest of the industry: EXENS outperforms 55.32% of its industry peers.
EXENS has a Debt/Equity ratio of 0.62. This is a neutral value indicating EXENS is somewhat dependend on debt financing.
EXENS has a Debt to Equity ratio (0.62) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 4.75 | ||
| Altman-Z | 4.21 |
ROIC/WACC1.07
WACC7.8%
2.3 Liquidity
EXENS has a Current Ratio of 2.94. This indicates that EXENS is financially healthy and has no problem in meeting its short term obligations.
EXENS's Current ratio of 2.94 is amongst the best of the industry. EXENS outperforms 93.62% of its industry peers.
A Quick Ratio of 2.07 indicates that EXENS has no problem at all paying its short term obligations.
EXENS has a better Quick ratio (2.07) than 91.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.94 | ||
| Quick Ratio | 2.07 |
3. Growth
3.1 Past
EXENS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 102.95%, which is quite impressive.
The Revenue has grown by 35.04% in the past year. This is a very strong growth!
The Revenue has been growing by 33.36% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)102.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
Revenue 1Y (TTM)35.04%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%-29%
3.2 Future
The Earnings Per Share is expected to grow by 30.13% on average over the next years. This is a very strong growth
Based on estimates for the next years, EXENS will show a quite strong growth in Revenue. The Revenue will grow by 12.83% on average per year.
EPS Next Y59.18%
EPS Next 2Y37.46%
EPS Next 3Y30.13%
EPS Next 5YN/A
Revenue Next Year18.72%
Revenue Next 2Y15.06%
Revenue Next 3Y12.83%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 53.65, the valuation of EXENS can be described as expensive.
EXENS's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.46. EXENS is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 25.18 indicates a quite expensive valuation of EXENS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXENS is on the same level as its industry peers.
EXENS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.65 | ||
| Fwd PE | 25.18 |
4.2 Price Multiples
EXENS's Enterprise Value to EBITDA ratio is in line with the industry average.
EXENS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.66 | ||
| EV/EBITDA | 20.2 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXENS's earnings are expected to grow with 30.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.91
PEG (5Y)N/A
EPS Next 2Y37.46%
EPS Next 3Y30.13%
5. Dividend
5.1 Amount
EXENS has a yearly dividend return of 0.25%, which is pretty low.
EXENS's Dividend Yield is slightly below the industry average, which is at 1.18.
Compared to an average S&P500 Dividend Yield of 2.34, EXENS's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.25% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y37.46%
EPS Next 3Y30.13%
EPA:EXENS (7/22/2025, 2:00:00 PM)
39.7
-0.8 (-1.98%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners42.16%
Inst Owner ChangeN/A
Ins Owners1.86%
Ins Owner ChangeN/A
Market Cap2.02B
Analysts78.75
Price Target38.91 (-1.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.25% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.65 | ||
| Fwd PE | 25.18 | ||
| P/S | 5.12 | ||
| P/FCF | 36.66 | ||
| P/OCF | 20.94 | ||
| P/B | 4.89 | ||
| P/tB | 110.91 | ||
| EV/EBITDA | 20.2 |
EPS(TTM)0.74
EY1.86%
EPS(NY)1.58
Fwd EY3.97%
FCF(TTM)1.08
FCFY2.73%
OCF(TTM)1.9
OCFY4.77%
SpS7.76
BVpS8.13
TBVpS0.36
PEG (NY)0.91
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.76% | ||
| ROE | 7.44% | ||
| ROCE | 10.15% | ||
| ROIC | 8.34% | ||
| ROICexc | 9.99% | ||
| ROICexgc | 29.84% | ||
| OM | 18.28% | ||
| PM (TTM) | 7.79% | ||
| GM | 73.86% | ||
| FCFM | 13.96% |
ROA(3y)2.89%
ROA(5y)N/A
ROE(3y)7.53%
ROE(5y)N/A
ROIC(3y)7.01%
ROIC(5y)N/A
ROICexc(3y)7.64%
ROICexc(5y)N/A
ROICexgc(3y)25.3%
ROICexgc(5y)N/A
ROCE(3y)8.53%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A
F-Score7
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 4.75 | ||
| Debt/EBITDA | 2.35 | ||
| Cap/Depr | 111.85% | ||
| Cap/Sales | 10.47% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 88.36% | ||
| Profit Quality | 179.26% | ||
| Current Ratio | 2.94 | ||
| Quick Ratio | 2.07 | ||
| Altman-Z | 4.21 |
F-Score7
WACC7.8%
ROIC/WACC1.07
Cap/Depr(3y)105.99%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.64%
Cap/Sales(5y)N/A
Profit Quality(3y)171.48%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
EPS Next Y59.18%
EPS Next 2Y37.46%
EPS Next 3Y30.13%
EPS Next 5YN/A
Revenue 1Y (TTM)35.04%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%-29%
Revenue Next Year18.72%
Revenue Next 2Y15.06%
Revenue Next 3Y12.83%
Revenue Next 5YN/A
EBIT growth 1Y45.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year73.48%
EBIT Next 3Y29.96%
EBIT Next 5YN/A
FCF growth 1Y181.68%
FCF growth 3Y33.59%
FCF growth 5YN/A
OCF growth 1Y90.75%
OCF growth 3Y31.16%
OCF growth 5YN/A